| Literature DB >> 28086790 |
Byung-Whi Kong1, Nicholas Hudson2, Dongwon Seo1, Seok Lee1, Bhuwan Khatri1, Kentu Lassiter1, Devin Cook1, Alissa Piekarski1, Sami Dridi1, Nicholas Anthony1, Walter Bottje3.
Abstract
BACKGROUND: Modern broiler chickens exhibit very rapid growth and high feed efficiency compared to unselected chicken breeds. The improved production efficiency in modern broiler chickens was achieved by the intensive genetic selection for meat production. This study was designed to investigate the genetic alterations accumulated in modern broiler breeder lines during selective breeding conducted over several decades.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28086790 PMCID: PMC5237145 DOI: 10.1186/s12864-016-3471-y
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1MA plots and number of DE genes. (a) MA plot for the comparison of PeM and BPR. (b) MA plot for mitoproteome genes of PeM vs. BPR. In (a) and (b), y and x axis represent the log ratio of differential expression and the average expression, respectively, for each gene in groups of PeM and BPR
Comparison of fold changes between RNAseq and qPCR
| PeM vs. BPR | ||
|---|---|---|
| Gene symbol | RNAseq* | qPCR* |
| MYH15 | 9.2 | 5.1 |
| TPM3 | 2.3 | 2.2 |
| MYOZ2 | 5.9 | 4.4 |
| TNNI1 | 5.7 | 24.7 |
| MSTN | 2.2 | 1.4 |
|
|
|
|
| PPARGC1A | −2.2 | −1.5 |
| PPARGC1B | −2.3 | −1.7 |
| FABP4 | 6.5 | 5.0 |
| CKMT1A | 1.6 | 1.3 |
| MB | 10.9 | 10.3 |
|
|
|
|
| CA3 | 30.3 | 4.6 |
| NOXO1 | 18.1 | 1.2 |
| MYBPC1 | 12.6 | 10.8 |
|
|
|
|
| GPM6A | −11.4 | −1.7 |
| PPDPF | −6.5 | −5.3 |
|
|
|
|
| CD9 | −5.9 | −4.5 |
* Values denote linear fold changes
** Inconsistent fold change between RNAseq and qPCR were italicized
Fig. 2A hierarchically clustered heatmap showing the expression patterns of the 40 most extreme DE mRNA. Red and blue represent up- and downregulated expression in PeM, respectively. Color density indicating levels of fold change was displayed
The 10 most differentially expressed genes in breast muscle tissue modern PeM broiler males compared to progenitor BPR broilers
| FC |
| Symbol | Entrez gene name |
|---|---|---|---|
| Up-regulation | |||
| 48.16 | 6.4E-05 | PLIN1 | perilipin 1 |
| 32.22 | 9.2E-07 | LMOD2 | leiomodin 2 (cardiac) |
| 30.27 | 7.9E-04 | CA3 | carbonic anhydrase III |
| 26.72 | 1.7E-07 | MUSTN1 | musculoskeletal, embryonic nuclear protein 1 |
| 20.96 | 1.2E-05 | TNNT2 | troponin T type 2 (cardiac) |
| 19.97 | 4.8E-06 | HSPB7 | heat shock 27 kDa protein family, member 7 (cardiovascular) |
| 18.12 | 1.0E-06 | NOXO1 | NADPH oxidase organizer 1 |
| 13.83 | 8.1E-05 | PLN | phospholamban |
| 12.99 | 2.8E-05 | PCSK1 | proprotein convertase subtilisin/kexin type 1 |
| 12.55 | 9.2E-04 | MYBPC1 | myosin binding protein C, slow type |
| Down-regulation | |||
| −13.36 | 9.6E-07 | IL23R | interleukin 23 receptor |
| −11.39 | 4.2E-05 | GPM6A | glycoprotein M6A |
| −8.81 | 1.5E-02 | KL | klotho |
| −7.72 | 7.8E-05 | AGMAT | agmatine ureohydrolase (agmatinase) |
| −7.72 | 1.1E-04 | DKK2 | dickkopf WNT signaling pathway inhibitor 2 |
| −7.21 | 1.4E-03 | GABRD | gamma-aminobutyric acid (GABA) A receptor, delta |
| −6.54 | 4.5E-03 | FGB | fibrinogen beta chain |
| −6.49 | 1.1E-06 | PPDPF | pancreatic progenitor cell differentiation and proliferation factor |
| −6.02 | 4.5E-06 | ACE | angiotensin I converting enzyme |
| −5.93 | 3.6E-05 | CD9 | CD9 molecule |
Biological functions of the 10 most up- and down-regulated genes
| Symbol | Functions |
|---|---|
| Up-regulation | |
| PLIN1 | • Is a member of the PLIN family, which has a specific role in regulating lipolysis |
| LMOD2 | • Is a member of tropomodulin family which is an actin filament elongation protein |
| CA3 | • Is a class of metalloenzymes that catalyze the reversible hydration of CO2
|
| MUSTN1 | • Expresses predominantly in the skeletal muscles and tendons in chicken and mammals [ |
| TNNT2 | • Is a tropomyosin binding subunit of the troponin complex, which is located on the thin filament of striated muscles |
| HSPB7 | • Is widely expressed throughout the body [ |
| NOXO1 | • Regulates NOX1 positively [ |
| PLN | • Is a major substrate for the cAMP-dependent protein kinase in cardiac muscle |
| PCSK1 | • Is a member of serine endopeptidase family |
| MYBPC1 | • Is a member of the myosin-binding protein C family |
| Down-regulation | |
| IL23R | • Associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner [ |
| GPM6A | • Plays a role as a modulator for neurite outgrowth and spine formation [ |
| KL | • Is a type-I membrane protein that is related to beta-glucosidases |
| AGMAT | • Converts agmatine to putrescine in the pathway of arginine-agmatine-polyamine pathway |
| DKK2 | • Antagonize Wnt signaling by binding to LRP5/6 and a single-transmembrane protein called Kreme [ |
| GABRD | • Is a ligand-gated chloride channel |
| FGB | • Is a blood-borne secreting glycoprotein |
| PPDPF | • Is also known as exocrine differentiation and proliferation factor (EXDPF) |
| ACE | • Involves in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. |
| CD9 | • Is a member of the transmembrane 4 superfamily, also known as the tetraspanin family |
Top diseases, molecular, cellular, and physiological functions for differentially expressed genes in PeM compared to BPR
| Functions |
| Molecules |
|---|---|---|
| Diseases and disorders | ||
| Organismal Injury and Abnormalities | 3.22E-02 | CXCL1, EGR1, IL13RA2, NOX4 |
| Molecular and Cellular Functions | ||
| Carbohydrate Metabolism | 2.19E-02 | ACACB, CRAT, FABP3, GFPT1, NHLRC1, NRG1, NUAK1, PKNOX1, PPARD, PPARG, PRKAA1, PRKAB2, PRKCB, PRKCD, UCP3, UGP2 |
| Cellular Growth and Proliferation | 2.18E-02 | ATM, DCN, MSTN, HEY1, MYC, MYF5, PITX2, PRNP |
| Small Molecule Biochemistry | 2.19E-02 | CRAT, NRG1, PKNOX1, PPARG, PRKAA1, PRKCD, UCP3 |
| Physiological System Development and Function | ||
| Skeletal and Muscular System Development and Function | 1.89E-02 | CALCRL, CHRNG, COL6A1, CRK, CXCL12, DES, DLG1, ELN, ESR2, FBN1, FN1, FST, HEY1, HLX, INPP5days, KLF2, LMO7, LOX, LPL, MB, MEOX2, MGP, MMP2, MSTN, MTM1, MYF5, NGFR, PITX2, PPARGC1A, SRPK3 |
| - Angiogenesis of Skeletal Muscle | 9.22E-03 | CXCL12, MYH9, PPARGC1A, PPARGC1B, VEGFA |
| Embryonic Development | 1.25E-02 | CAPN3, CSRP3, CXCL12, ELN, GPCPD1, HLX, MEOX2, MSC, MSTN, MYF5, MYH9, PITX2, PPARGC1A, PPARGC1B, RGS2, SIX1, SRPK3, SVIL, UTRN, VEGFA26 |
Fig. 3PDGF signaling pathway. Green, red, orange and blue represent down-regulation, up-regulation, predicted up-regulation and predicted down-regulation, respectively. Symbols for each molecule are presented according to molecular functions and type of interactions. Prediction legends showed color schemes of shapes and connecting lines
Fig. 4NRF2 mediated oxidative stress pathway. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3. White symbols indicate neighboring genes that are functionally associated, but not included in the DE gene list
DE genes in NFE2L2 mediated oxidative stress
| Symbol | Entrez gene name | Fold change |
| Location | Type (s) |
|---|---|---|---|---|---|
| ATM | ATM serine/threonine kinase | −1.31 | 3.95E-02 | Nucleus | kinase |
| CAT | catalase | 1.67 | 7.26E-05 | Cytoplasm | enzyme |
| DNAJB5 | DnaJ (Hsp40) homolog, subfamily B, member 5 | 1.56 | 1.61E-02 | Cytoplasm | other |
| DNAJB6 | DnaJ (Hsp40) homolog, subfamily B, member 6 | 1.30 | 5.86E-03 | Nucleus | transcription regulator |
| DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | −1.45 | 1.94E-03 | Nucleus | other |
| DNAJC15 | DnaJ (Hsp40) homolog, subfamily C, member 15 | −1.39 | 2.04E-02 | Cytoplasm | other |
| DNAJC21 | DnaJ (Hsp40) homolog, subfamily C, member 21 | −1.97 | 3.50E-05 | Other | other |
| EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 1.39 | 1.03E-02 | Cytoplasm | kinase |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 4.66 | 1.06E-02 | Nucleus | transcription regulator |
| HMOX1 | heme oxygenase 1 | 2.53 | 7.47E-04 | Cytoplasm | enzyme |
| HRAS | Harvey rat sarcoma viral oncogene homolog | 1.43 | 1.51E-03 | Plasma Membrane | enzyme |
| JUN | jun proto-oncogene | 2.45 | 2.23E-03 | Nucleus | transcription regulator |
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 1.33 | 1.13E-02 | Cytoplasm | kinase |
| MAP2K6 | mitogen-activated protein kinase kinase 6 | −1.85 | 1.31E-02 | Cytoplasm | kinase |
| MGST1 | microsomal glutathione S-transferase 1 | 1.36 | 3.58E-02 | Cytoplasm | enzyme |
| MRAS | muscle RAS oncogene homolog | 1.53 | 4.77E-02 | Plasma Membrane | enzyme |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | −1.34 | 1.15E-02 | Cytoplasm | kinase |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | −2.66 | 1.05E-03 | Cytoplasm | kinase |
| PRKCB | protein kinase C, beta | 2.28 | 2.15E-03 | Cytoplasm | kinase |
| PRKCD | protein kinase C, delta | 1.41 | 2.50E-02 | Cytoplasm | kinase |
| PRKCH | protein kinase C, eta | −2.95 | 7.23E-04 | Cytoplasm | kinase |
| SOD3 | superoxide dismutase 3, extracellular | 2.51 | 1.48E-02 | Extracellular Space | enzyme |
| TXNRD1 | thioredoxin reductase 1 | 1.74 | 7.60E-04 | Cytoplasm | enzyme |
DE genes in oxidative stress pathway
| Symbol | Entrez gene name | Fold change |
| Location | Type (s) |
|---|---|---|---|---|---|
| CAT | catalase | 1.67 | 7.26E-05 | Cytoplasm | enzyme |
| CCL5 | chemokine (C-C motif) ligand 5 | 4.47 | 3.90E-04 | Extracellular Space | cytokine |
| DUSP1 | dual specificity phosphatase 1 | 2.73 | 4.81E-03 | Nucleus | phosphatase |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 4.66 | 1.06E-02 | Nucleus | transcription regulator |
| JUN | jun proto-oncogene | 2.45 | 2.23E-03 | Nucleus | transcription regulator |
| MGST1 | microsomal glutathione S-transferase 1 | 1.36 | 3.58E-02 | Cytoplasm | enzyme |
| PRDX4 | peroxiredoxin 4 | 1.40 | 1.35E-02 | Cytoplasm | enzyme |
| SOD3 | superoxide dismutase 3, extracellular | 2.51 | 1.48E-02 | Extracellular Space | enzyme |
| STAT3 | signal transducer and activator of transcription 3 | 1.30 | 7.34E-04 | Nucleus | transcription regulator |
| VCAM1 | vascular cell adhesion molecule 1 | 1.50 | 2.49E-02 | Plasma Membrane | transmembrane receptor |
| XDH | xanthine dehydrogenase | 3.86 | 1.78E-04 | Cytoplasm | enzyme |
Fig. 5DE genes regulated by MSTN. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3
Fig. 6DE genes regulated by PRKAG3. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3
Fig. 7DE genes regulated by LIPE. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3
Fig. 8DE genes regulated by androgen receptor (AR). Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3